CrossrefInfokarte
Sustained Improvement in Atopic Dermatitis Disease Control and Treatment Satisfaction With Dupilumab in Clinical Practice: 7-Year Follow-up Results From the RELIEVE-AD Study
SKIN The Journal of Cutaneous Medicine · 2026-11-10 · 10 (6) · s828
DOI: 10.25251/7nntvy16 ↗Abstract
Objective: To report 7-year outcomes of dupilumab in AD disease control and treatment satisfaction from the RELIEVE-AD study.
EUVIMED